NANOLEK was granted an extension of the market authorization for Nebivolol-NANOLEK. The corresponding entry LP-003049 was made in the State register of medicines.

The drug has been manufactured at the NANOLEK biomecial complex in the Kirov region since 2015. The plant produces an average of 80,000 packages per year.

Nebivolol-NANOLEK is used to treat arterial hypertension, coronary heart disease, angina of effort.